These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32185065)

  • 1. Cavitary lesions emerged rapidly in
    Kawakami N; Ohara S; Namkoong H
    Clin Case Rep; 2020 Mar; 8(3):576-577. PubMed ID: 32185065
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-acquired necrotizing pneumonia with bacteremia caused by Pseudomonas aeruginosa in a patient with emphysema: An autopsy case report.
    Sakamoto N; Tsuchiya K; Hikone M
    Respir Investig; 2018 Mar; 56(2):189-194. PubMed ID: 29548659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-Acquired Cavitary
    Woods E; Cohen G; Bressman E; Lin D; Zeitouni NE; Beckford C; Hamula C; van Bakel H; Sullivan M; Altman DR; Caplivski D
    Case Rep Infect Dis; 2017; 2017():5474916. PubMed ID: 29527364
    [No Abstract]   [Full Text] [Related]  

  • 4. Community-acquired lobar pneumonia caused by Pseudomonas aeruginosa infection in Japan: a case report with histological and immunohistochemical examination.
    Takajo D; Iwaya K; Katsurada Y; Miyai K; Takasu A; Matsubara O; Sakamoto T; Tamai S; Tsuda H
    Pathol Int; 2014 May; 64(5):224-30. PubMed ID: 24888776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired Pseudomonas aeruginosa pneumonia manifested by bloody pleural effusion in a previously healthy infant: A case report.
    Dong C; Shen F; Dong H; Dong L; Fu Y; Xu Y; Ning J
    J Clin Lab Anal; 2022 Jun; 36(6):e24466. PubMed ID: 35561264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man.
    Kunimasa K; Ishida T; Kimura S; Tanaka M; Kouyama Y; Yamashita S; Morita M; Tachibana H; Tokioka F; Ito A; Sumi C; Tateda K
    Intern Med; 2012; 51(17):2473-8. PubMed ID: 22975571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrotizing
    Maharaj S; Isache C; Seegobin K; Chang S; Nelson G
    Case Rep Infect Dis; 2017; 2017():1717492. PubMed ID: 28596927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period.
    Yayan J; Ghebremedhin B; Rasche K
    PLoS One; 2015; 10(10):e0139836. PubMed ID: 26430738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired Pseudomonas aeruginosa pneumonia in patients with HIV infection.
    Schuster MG; Norris AH
    AIDS; 1994 Oct; 8(10):1437-41. PubMed ID: 7818814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa.
    Fujii A; Seki M; Higashiguchi M; Tachibana I; Kumanogoh A; Tomono K
    Respir Med Case Rep; 2014; 12():30-3. PubMed ID: 26029534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factor Evaluation for Methicillin-Resistant
    Lewis PO
    Ann Pharmacother; 2021 Jan; 55(1):36-43. PubMed ID: 32545992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination Therapy of Polymyxin B and Amikacin for Community-Acquired
    Wang J; Yun L; Zhao H; Li X
    Infect Drug Resist; 2021; 14():2895-2900. PubMed ID: 34349524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia.
    Sibila O; Laserna E; Maselli DJ; Fernandez JF; Mortensen EM; Anzueto A; Waterer G; Restrepo MI
    Respirology; 2015 May; 20(4):660-6. PubMed ID: 25776134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the in-hospital costs of Pseudomonas aeruginosa pneumonia: methodology and results from a German teaching hospital.
    Kaier K; Heister T; Götting T; Wolkewitz M; Mutters NT
    BMC Infect Dis; 2019 Dec; 19(1):1028. PubMed ID: 31795953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two Cases of Rapidly Progressive Community-acquired Pneumonia Due to Pseudomonas aeruginosa].
    Takakura A; Katono K; Harada S; Igawa S; Katagiri M; Yanase N; Masuda N
    Kansenshogaku Zasshi; 2015 Jan; 89(1):56-61. PubMed ID: 26548298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia.
    Wijit K; Sonthisombat P; Diewsurin J
    BMC Infect Dis; 2023 Oct; 23(1):700. PubMed ID: 37858082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa identified as a key pathogen in hospitalised children with aspiration pneumonia and a high aspiration risk.
    Ashkenazi-Hoffnung L; Ari A; Bilavsky E; Scheuerman O; Amir J; Prais D
    Acta Paediatr; 2016 Dec; 105(12):e588-e592. PubMed ID: 27387674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.
    Cillóniz C; Gabarrús A; Ferrer M; Puig de la Bellacasa J; Rinaudo M; Mensa J; Niederman MS; Torres A
    Chest; 2016 Aug; 150(2):415-25. PubMed ID: 27060725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of community-acquired Pseudomonas aeruginosa pneumonia complicated with MODS in a previously healthy patient and related literature review.
    Wang T; Hou Y; Wang R
    BMC Infect Dis; 2019 Feb; 19(1):130. PubMed ID: 30736735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment.
    Larcher R; Pantel A; Arnaud E; Sotto A; Lavigne JP
    BMC Infect Dis; 2017 Jul; 17(1):477. PubMed ID: 28683724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.